| ²é¿´: 757 | »Ø¸´: 1 | ||
icyuhand½ð³æ (СÓÐÃûÆø)
³ôƤ
|
[ÇóÖú]
¡¾ÊµÑéÇóÖú¡¿ÑÛµ×£¨²¿£©ÐÂÉúѪ¹ÜÄ£ÐÍ/ÌåÍâ¡¢ÌåÄÚʵÑé
|
|
¸÷λÖ÷ÈΡ¢ÀÏʦ£¬´ó¼ÒºÃ£º ±¾ÈËÊÇҩѧרҵѧÉú£¬¿ÎÌâ×é·¢ÏÖÁËÒ»¸öÐµĻ¯ºÏÎÓкÜÇ¿µÄÒÖÖÆÐÂÉúѪ¹ÜµÄ×÷Óã¬ÏëÓ¦ÓÃÔÚÖÎÁÆÑÛµ×£¨²¿£©ÐÂÉúѪ¹ÜÁìÓò£¬ÌØ´ËÀ´Ïò¸÷λÀÏʦÇë½Ì¹ØÓÚÑÛµ×£¨²¿£©ÐÂÉúѪ¹ÜÄ£Ðͼ°ÈçºÎÌåÍâ¡¢ÌåÄÚʵÑéµÄÎÊÌâ¡£ ¾¹ý²éÔÄ×ÊÁÏ£¬ÓÐһƪÂÛÎÄÓÐÈçϵĶÔÓÚл¯ºÏÎï¶ÔÑÛ²¿ÐÂÉúѪ¹ÜµÄÑо¿Ë¼Â·£º 1.Ex ovo chick chorioallantoic membrane assay 2.Silver nitrate cauterisation-induced corneal neovascularisation model 3.Argon-laser photocoagulation-induced choroidal neovascularisation assay 4.Oxygen-induced retinopathy neovascularisation assay 5.Protein expression analysis£¨Human umbilical vein endothelial cells£¬VEGF¡¢PEDF¡¢GAPDH£© ¸Ã˼·»ù±¾´ó²¿·Ö¶¼ÊÇÓö¯Îィ죬µ«ÊÇĿǰÎÒÃÇ·ÇÑÛ¿Æ×¨ÒµÑ§ÉúºÜÄѲÙ×÷£¬Çë½Ì¸÷λÀÏʦ£¬ÓÐûÓмòµ¥µÄ·½·¨£¬±ÈÈç°ëÌåÍâ¡¢Æ÷¹Ù»òÕßϸ°ûѧģÐÍ£¬¿ÉÒÔÑéÖ¤Ò©Îï¶ÔÑÛ²¿ÐÂÉúѪ¹ÜÉú³ÉµÄ×÷ÓÃÄØ£¿ лл¸÷λÀÏʦ£¬Çë¸÷λÀÏʦ²»Áߴͽ̣¡ |
» ²ÂÄãϲ»¶
ÏßÁ£Ìå+´úÐ»ÖØ±à³Ì+Ìǽͽâ+×ÔÊÉËÄ´ó¹ú×ÔÈ»ÈȵãÆë¾ÛÒ»ÌÃ
ÒѾÓÐ7È˻ظ´
¸É»õ·ÖÏí | ´øÄã¿ìËÙÈëÃÅJAK/STAT signaling pathwaysÐźÅͨ·
ÒѾÓÐ0È˻ظ´
ÖÐҽѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ139È˻ظ´
±ê׼ƷºÍ¶ÔÕÕÆ·ÓÐÄÄЩ²»Ò»Ñù£¿
ÒѾÓÐ0È˻ظ´
¸É»õ·ÖÏí | ϸ°û¸´ËÕ¼¼ÇÉ£¬MDL¿ÆÑÐÖúÊÖÀ´Ö§ÕÐ
ÒѾÓÐ0È˻ظ´
¸É»õ·ÖÏí | ÁܰÍϸ°ûºÍNKϸ°û£¬ÊÇÈçºÎÉú³ÉµÄ£¿
ÒѾÓÐ5È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÌåÍâʵÑéÄ£Ðͽ¨Á¢Ï¸°ûÑ¡ÔñºÍÆÀ¼Û·½·¨
ÒѾÓÐ3È˻ظ´

jms_guan
ר¼Ò¹ËÎÊ (ÖøÃûдÊÖ)
- MedEPI: 7
- Ó¦Öú: 70 (³õÖÐÉú)
- ¹ó±ö: 0.017
- ½ð±Ò: 4734.7
- É¢½ð: 546
- ºì»¨: 14
- Ìû×Ó: 1101
- ÔÚÏß: 121.3Сʱ
- ³æºÅ: 845276
- ×¢²á: 2009-09-11
- ÐÔ±ð: GG
- רҵ: ÈËÀàÓªÑø
- ¹ÜϽ: ÉúÎïÒ½Ò©Çø

2Â¥2014-04-03 22:43:20











»Ø¸´´ËÂ¥
10